NSTG logo

NanoString Technologies, Inc.

NSTG

NSTG: NanoString Technologies Inc is engaged in the development, manufacturing and commercialization of instruments, consumables, and services for efficiently profiling the activity of hundreds of genes and proteins simultaneously from a single tissue sample. Its core technology includes proprietary chemistries that enable the labeling and counting of single molecules. The firm uses its technology to develop tools for scientific and clinical research, primarily in the fields of genomics and proteomics. It offers two product platforms such as nCounter Analysis System or nCounter, and GeoMx Digital Spatial Profiler or DSP system both include instruments, related consumables, and software. NanoString Technologies generates revenue from the sale of products and related services and collaborations.

more

Show NSTG Financials

Chart and Financial Data provided by TradingView

All
Government
Consumer Interest
SEC Filings
ESG/Other
Congress Trading

Recent trades of NSTG by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by NSTG's directors and management

Corporate Lobbying

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Simultaneous quantification of gene expression in a user-defined region of a cross-sectioned tissue Jul. 25, 2023
  • Patent Title: Chemical compositions and methods of using same Jan. 10, 2023
  • Patent Title: Chemical compositions and uses thereof Oct. 18, 2022
  • Patent Title: Chemical compositions and uses thereof Jul. 05, 2022
  • Patent Title: Chemical compositions and methods of using same Mar. 22, 2022
  • Patent Title: Methods and apparatuses for gene purification and imaging Aug. 24, 2021
  • Patent Title: Simultaneous quantification of gene expression in a user-defined region of a cross-sectioned tissue May. 05, 2020
  • Patent Title: Simultaneous quantification of a plurality of proteins in a user-defined region of a cross-sectioned tissue Dec. 10, 2019
  • Patent Title: Chemical compositions and methods of using same Sep. 17, 2019
  • Patent Title: Methods and apparatuses for gene purification and imaging Apr. 02, 2019
  • Patent Title: Stable nanoreporters Sep. 18, 2018
  • Patent Title: Protein detection via nanoreporters Jun. 12, 2018
  • Patent Title: Nanoreporters and methods of manufacturing and use thereof Feb. 13, 2018
  • Patent Title: Stable nanoreporters Jan. 02, 2018
  • Patent Title: Compositions and methods for diagnosing cancer Sep. 12, 2017
  • Patent Title: Protein detection via nanoreporters Jul. 25, 2017
  • Patent Title: Compositions and methods for the detection of small rnas Jul. 25, 2017
  • Patent Title: Fluorescent nucleic acid probe detection cartridge assembly unit May. 23, 2017
  • Patent Title: Stable nanoreporters Jun. 28, 2016
  • Patent Title: Nanoreporters and methods of manufacturing and use thereof Jun. 21, 2016
  • Patent Title: Compositions comprising oriented, immobilized macromolecules and methods for their preparation Mar. 24, 2015
  • Patent Title: Stable nanoreporters Aug. 27, 2013
  • Patent Title: Methods and computer systems for identifying target-specific sequences for use in nanoreporters Apr. 09, 2013
  • Patent Title: Systems and methods for analyzing nanoreporters May. 10, 2011
  • Patent Title: Methods for detection and quantification of analytes in complex mixtures Apr. 05, 2011
Government Contracts

Federal grants, loans, and purchases

WallStreetBets

Number of mentions of NSTG in WallStreetBets Daily Discussion

NSTG News

Recent insights relating to NSTG

CNBC Recommendations

Recent picks made for NSTG stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in NSTG

Corporate Flights

Flights by private jets registered to NSTG